PALISADE BIO, INC. — Operating Income by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/7ec0e85c-5210-495c-9cea-dfc9d95a6323/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-18.1M | 2025-01-01 – 2025-12-31 | evidence 0001357459-26-000004 |
| FY 2024 | $-14.9M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-043859 |
| FY 2023 | $-13.1M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-036402 |
| FY 2022 | $-15.7M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-009226 |
| FY 2021 | $-41.9M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-004093 |
| FY 2020 | $-9.3M | 2020-01-01 – 2020-12-31 | evidence 0000950170-22-004093 |
| FY 2019 | $-8.6M | 2019-01-01 – 2019-12-31 | evidence 0001171843-20-002061 |
| FY 2018 | $-8.3M | 2018-01-01 – 2018-12-31 | evidence 0001171843-19-001917 |
| FY 2017 | $-13.3M | 2017-01-01 – 2017-12-31 | evidence 0001171843-18-002404 |
| FY 2016 | $-20.6M | 2016-01-01 – 2016-12-31 | evidence 0001171843-17-001704 |
| FY 2015 | $-19.2M | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-087765 |
| FY 2014 | $-17.4M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-016085 |
| FY 2013 | $-12.5M | 2013-01-01 – 2013-12-31 | evidence 0001144204-14-014279 |
| FY 2012 | $-10.2M | 2012-01-01 – 2012-12-31 | evidence 0001144204-13-015444 |
| FY 2011 | $-13.0M | 2011-01-01 – 2011-12-31 | evidence 0001144204-12-018248 |
| FY 2010 | $-15.2M | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-018248 |
| FY 2009 | $-10.5M | 2009-01-01 – 2009-12-31 | evidence 0001144204-12-018248 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).